Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Activity profile of beta blockers]

H Drexel1

  • 1Departement für Innere Medizin, Universitätsspital, Zürich.

Praxis
|March 7, 1995
PubMed
Summary

Beta-adrenergic blockers vary in effects. Key features include beta-1 specificity, hydrophilicity, duration, antiarrhythmic potency, and intrinsic sympathomimetic activity (ISA).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-Specific Disparities in Lipid-Based Prediction of Major Cardiovascular Events.

European journal of preventive cardiology·2025
Same author

Evaluation of circulating glypican 4 as a novel biomarker in disease - A comprehensive review.

Journal of molecular medicine (Berlin, Germany)·2025
Same author

Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.

Diabetes, obesity & metabolism·2024
Same author

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease.

European cardiology·2020
Same author

Gender differences in the effects of cardiovascular drugs.

European heart journal. Cardiovascular pharmacotherapy·2017
Same author

Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.

International journal of laboratory hematology·2014

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Context:

  • Beta-adrenergic blockers are a class of drugs with diverse pharmacological profiles.
  • Understanding these differences is crucial for effective therapeutic use.

Purpose:

  • To delineate the key characteristics that differentiate beta-adrenergic blockers.
  • To define an ideal profile for beta-adrenergic blocking agents.

Summary:

  • Beta-adrenergic blockers exhibit heterogeneity in beta-1 specificity, hydrophilicity, duration of action, antiarrhythmic potency, and intrinsic sympathomimetic activity (ISA).
  • Hydrophilicity correlates with duration of action.
  • Higher beta-1 specificity is associated with weaker metabolic effects.

Impact:

  • Provides a framework for classifying and comparing beta-adrenergic blockers.
  • Informs the selection of appropriate beta-blockers for specific clinical applications.
  • Highlights the importance of a balanced pharmacological profile for optimal therapeutic outcomes.

Related Experiment Videos